Colossal Biosciences Raises $200 Million For De-Extinction Effort
On Jan. 16, 2025, Colossal Biosciences – the company behind an ambitious, Jurassic Park-style effort to revive extinct bird and…
Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
Biotechnology | COVID-19 | Diagnostics | NIH | Oncology | Therapeutics | Women's Health
New cancer diagnoses did not rebound as expected following pandemic
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
False-positive mammogram results discourage some women from future screenings
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
U.S. Preventive Services Task Force recommended all women get screened for breast cancer every other year aged 40 to 74
On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
U.S. Preventive Services Task Force recommended biennial screening mammography for women aged 50 to 74 years
On Jan. 11, 2016, the U.S. Preventive Services Task Force (USPSTF) recommended biennial screening mammography for women aged…
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health
Seattle Cancer Care Alliance introduced the Mammovan, making digital mammography more accessible
In 2008, the Seattle Cancer Care Alliance introduced the Mammovan, making digital mammography more accessible to women throughout…
MRI detected cancers in the opposite breast of women newly diagnosed with breast cancer
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
Preliminary results from clinical trial of digital vs. film mammography showed no difference in breast cancer detection
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
Biotechnology | Diagnostics | Disease | FDA | Nanotechnology | Oncology | Therapeutics
FDA approved albumin-stabilized nanoparticle formulation of paclitaxel for treatment of breast cancer
In Jan. 2005, the U.S. Food and Drug Administration (FDA) approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane)…
The Huntsman Cancer Center Hospital opened
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
Gateway Building opened at Virginia Commonwealth University Medical Center
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
Biotechnology | Diagnostics | Disease | Medical Device | Oncology | Radiology | U.S. Congress | Women's Health
Mammography Quality Standards Reauthorization Act continued 1992 Act until 2002
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
National Cancer Advisory Board recommended women age 40 years and older receive screening mammograms every one to two years
In March 1997, the American Cancer Society (ACS) updated its recommended mammography screening interval for women ages 40-49…
The Mammography Quality Standards Act was passed
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
Mammography Quality Standards Act required all mammography facilities in the U.S. to be accredited and federally certified
On Oct. 7, 1992, all U.S. mammography facilities, except those managed by the Department of Veterans Affairs, must…
The Mallinckrodt of Radiology introduced the first mobile mammography unit in the St. Louis region
In 1986, the Mallinckrodt Institute of Radiology and the former Barnes Hospital introduced the first mobile mammography unit…
Biology | Diagnostics | Disease | Life Science History | Oncology | Radiology | Therapeutics | Women's Health
The Health Insurance Plan (HIP) of Greater New York Study began
In 1963, The Health Insurance Plan (HIP) of Greater New York Study began. HIP was the first randomized…